LAURIE BLACK: Open Payments
NPI 1376109736 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 45 payments from 20 companies in 2025. Trend: 2023 $2,015 · 2024 $1,160 · 2025 $1,140
Food & beverage: $1,093Education: $47
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $388 |
| HARMONY BIOSCIENCES LLC | 3 | $127 |
| UCB, Inc. | 4 | $108 |
| Amgen Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $52 |
| Alexion Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: QULIPTA, WAKIX, Nayzilam, UBRELVY, UPLIZNA, ULTOMIRIS, NURTEC ODT, KESIMPTA.
Industry payments across IN — which companies pay providers there.
